Last reviewed · How we verify
HR17031 injection ;INS068 injection;SHR20004 injection — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HR17031 injection ;INS068 injection;SHR20004 injection (HR17031 injection ;INS068 injection;SHR20004 injection) — Jiangsu HengRui Medicine Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HR17031 injection ;INS068 injection;SHR20004 injection TARGET | HR17031 injection ;INS068 injection;SHR20004 injection | Jiangsu HengRui Medicine Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HR17031 injection ;INS068 injection;SHR20004 injection CI watch — RSS
- HR17031 injection ;INS068 injection;SHR20004 injection CI watch — Atom
- HR17031 injection ;INS068 injection;SHR20004 injection CI watch — JSON
- HR17031 injection ;INS068 injection;SHR20004 injection alone — RSS
Cite this brief
Drug Landscape (2026). HR17031 injection ;INS068 injection;SHR20004 injection — Competitive Intelligence Brief. https://druglandscape.com/ci/hr17031-injection-ins068-injection-shr20004-injection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab